In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
SHOPPING: Shoppers are turning to Calocrub Supplements for faster, more effective weight loss claiming it's better than ...
The Punch Newspapers on MSN1d
Rebel Wilson Weight Loss Transformation JourneyYou've probably seen the headlines about Rebel Wilson's incredible weight loss transformation. The actress, known for ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Live Science on MSN19h
Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
Stockhead on MSN1d
Ozempic’s PBS push could shake up ASX food stocks, and here’s howBig pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions, and more ...
1don MSNOpinion
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback